Globus Medical, Inc.

GMED · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$103$123$190$149
Dep. & Amort.$254$145$68$70
Deferred Tax-$126-$58-$22-$18
Stock-Based Comp.$54$53$33$31
Change in WC-$98-$117-$105-$17
Other Non-Cash$333$98$15$61
Operating Cash Flow$521$243$178$276
Investing Activities
PP&E Inv.-$115-$78-$74-$57
Net Acquisitions-$18-$296-$31-$34
Inv. Purchases-$114-$101-$420-$622
Inv. Sales/Matur.$71$778$415$338
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$176$303-$110-$376
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$86-$226-$144$0
Dividends Paid$0$0$0$0
Other Fin. Act.$58-$6$35$54
Financing Cash Flow-$28-$232-$110$54
Forex Effect$0$2-$1-$1
Net Chg. in Cash$317$317-$43-$46
Supplemental Information
Beg. Cash$467$150$193$239
End Cash$784$467$150$193
Free Cash Flow$405$165$104$219
Globus Medical, Inc. (GMED) Financial Statements & Key Stats | AlphaPilot